An Open Label, Comparative, Randomised, Balanced Crossover Trial Comparing Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Breakthrough Pain in Patients With Cancer.

Trial Profile

An Open Label, Comparative, Randomised, Balanced Crossover Trial Comparing Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Breakthrough Pain in Patients With Cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Aug 2014

At a glance

  • Drugs Fentanyl (Primary) ; Fentanyl
  • Indications Cancer pain
  • Focus Therapeutic Use
  • Sponsors Takeda
  • Most Recent Events

    • 23 Jun 2012 Inclusion and exclusion criteria amended as reported by European Clinical Trials Database record.
    • 23 Jun 2012 Additional locations added as reported by European Clinical Trials Database record.
    • 04 May 2012 Company added in association field as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top